Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Reilly

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Blood|November 8, 2008
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentFrancisco Cervantes, Brigitte Dupriez, Arturo Pereira, et al.
Haematologica|September 9, 2010
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasmsPhilip A Beer, Christina A Ortmann, Frank Stegelmann, et al.
British Journal of Haematology|June 18, 2014
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemiaClaire N Harrison, Nauman Butt, Peter Campbell, et al.
Blood|March 13, 2009
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conferenceGiovanni Barosi, Gunnar Birgegard, Guido Finazzi, et al.
British Journal of Haematology|June 5, 2003
Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemiasRory S Care, Peter J M Valk, Anne C Goodeve, et al.
Haematologica|September 26, 2008
Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disordersNasios Fourouclas, Juan Li, Daniel C Gilby, et al.
British Journal of Haematology|November 26, 2009
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus processGiovanni Barosi, Gunnar Birgegard, Guido Finazzi, et al.
Blood|July 5, 2005
Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)Giovanni Barosi, Dominique Bordessoule, Jean Briere, et al.
British Journal of Haematology|June 26, 2014
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012John T Reilly, Mary Frances McMullin, Philip A Beer, et al.
The New England Journal of Medicine|July 8, 2005
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemiaClaire N Harrison, Peter J Campbell, Georgina Buck, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Blood|November 8, 2008
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentFrancisco Cervantes, Brigitte Dupriez, Arturo Pereira, et al.
Haematologica|September 9, 2010
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasmsPhilip A Beer, Christina A Ortmann, Frank Stegelmann, et al.
British Journal of Haematology|June 18, 2014
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemiaClaire N Harrison, Nauman Butt, Peter Campbell, et al.
Blood|March 13, 2009
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conferenceGiovanni Barosi, Gunnar Birgegard, Guido Finazzi, et al.
British Journal of Haematology|June 5, 2003
Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemiasRory S Care, Peter J M Valk, Anne C Goodeve, et al.
Haematologica|September 26, 2008
Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disordersNasios Fourouclas, Juan Li, Daniel C Gilby, et al.
British Journal of Haematology|November 26, 2009
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus processGiovanni Barosi, Gunnar Birgegard, Guido Finazzi, et al.
Blood|July 5, 2005
Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)Giovanni Barosi, Dominique Bordessoule, Jean Briere, et al.
British Journal of Haematology|June 26, 2014
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012John T Reilly, Mary Frances McMullin, Philip A Beer, et al.
The New England Journal of Medicine|July 8, 2005
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemiaClaire N Harrison, Peter J Campbell, Georgina Buck, et al.
Pageof 8